// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Differences in morphokinetic patterns and clinical outcomes between fresh and frozen oocytes; a retrospective analysis

L Abreu - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Infertility

N/A

Exposure to triclosan modifies oocyte development and embryo metabolism

V Papachristofi - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alora

Embryonic quality assessment from microRNA profiling

A Almutlaq - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

‘Augmented intelligence’ to possibly shorten euploid identification time: A human-machine interaction study for euploid identification using ERICA, an Artificial Intelligence software to assist embryo ranking

A Chavez Badiola - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of Direct Unequal Cleavage (DUC on embryo development, blastocyst formation and ploidy - artificial intelligence (AI analysis

A Florek - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Potential for improvement and current limitations of Artificial Intelligence (AI for embryo selection: analysis of external validation data

I Sfontouris - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Optimising vaginal biospecimen collection

F Turner - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Spontaneous preterm delivery

N/A

Effect of male body mass index on miscarriage rate following fertility treatment, a systematic review and meta-analysis

R Halimeh - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Spontaneous abortion

N/A

The association between embryo morphology and first trimester miscarriage after single blastocyst transfer

A Yeung - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Ectopic pregnancy

N/A

Assessing women’s preferences in a novel intrauterine device designed to monitor the womb environment in real time: A discrete choice experiment

K.Y.B Ng - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Betahistine Hydrochloride

Ultrastructural and functional defects in cilia of endometrial glands from women with reproductive failure

J Pearson-Farr - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

The ABC of fertility intentions: a mixed-methods study exploring the spectrum of attitudes towards family building

J Shawe - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Fertility in the workplace: The emotional, physical and psychological impact of infertility in the workplace

F Steyn - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Infertility

N/A

Subclinical hypothyroidism and antithyroid autoantibodies in women with subfertility or recurrent pregnancy loss: a scientific impact paper

R Dhillon-Smith - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Subclinical hypothyroidism

Levothyroxine

Genomic analyses in 101,127 UK women show that previously reported monogenic genes are not common causes of premature ovarian insufficiency

S Shekari - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Premature ovarian failure

N/A

Emerging mechanisms of oocyte genome integrity

S Dunkley - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Surgery versus IVF/ICSI in infertile women with rectosigmoid endometriosis: the FERTILITY-RECTOSIGMOID study

F Barra - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Endometriosis

N/A

Reproductive outcomes in women with Borderline Ovarian Tumours. Does fertility treatment increase the risk of disease recurrence?

L Kasaven - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Has time-lapse technology finally proven its clinical benefit?

S Armstrong - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The type of gonadotrophin: Does it improve ART outcome?

S.K Sunkara - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Ovarian hyperstimulation syndrome

N/A

Copyright © 2026. QuantiNova All rights reserved